Thursday, Sept. 8, 2005 | 9:43 a.m.
The New York Stock Exchange unexpectedly postponed the listing Wendesday of a company that uses animals to test drugs and other products amid phone and e-mail protests from animal-rights groups.
Life Sciences Research Inc., the parent of Huntingdon Life Sciences Plc, was scheduled to begin trading at the Big Board Wednesday. The company's chief financial officer went to the exchange to observe the new listing before the NYSE told him it was cancelled.
"The company is very disappointed," said CFO Richard Michaelson. "We learned about it this morning. They didn't make it clear to us what their process was."
NYSE spokesman Ray Pellecchia didn't return calls seeking comment. Life Sciences will continue to trade on the Nasdaq Stock Market's Over-the-Counter Bulletin Board. Michaelson said he did not know how long the listing would be postponed.
archive
